Tag Archives: Celgene

Celgene (CELG): New Buy Recommendation for This Healthcare Giant

Mizuho Securities analyst Salim Syed maintained a Buy rating on Celgene (CELG – Research Report) today and set a price target of $103. The company’s shares closed yesterday at $94.96, close to its 52-week high of $97.07. According to TipRanks.com,

Cantor Fitzgerald Keeps a Buy Rating on Celgene (CELG)

Cantor Fitzgerald analyst Alethia Young reiterated a Buy rating on Celgene (CELG – Research Report) yesterday and set a price target of $100. The company’s shares closed yesterday at $83.12. Young wrote: “: Reiterate Overweight rating and $100 price target.

A Director at Celgene (NASDAQ: CELG) is Buying Shares

Today, a Director at Celgene (CELG – Research Report), Ernest Mario, bought shares of CELG for $180K. Following this transaction Ernest Mario’s holding in the company was increased by 617.28% to a total of $5.46 million. Following Ernest Mario’s last

Celgene (CELG) Gets a Buy Rating from Cantor Fitzgerald

Cantor Fitzgerald analyst Alethia Young reiterated a Buy rating on Celgene (CELG – Research Report) yesterday and set a price target of $100. The company’s shares closed yesterday at $88.46. Young observed: “. We reiterate our Overweight rating and $100

Celgene (CELG) Gets a Hold Rating from Wells Fargo

Wells Fargo analyst Jim Birchenough maintained a Hold rating on Celgene (CELG – Research Report) today. The company’s shares opened today at $87.86. According to TipRanks.com, Birchenough is a 5-star analyst with an average return of 19.9% and a 46.8%

Cantor Fitzgerald Sticks to Their Buy Rating for Celgene (CELG)

Cantor Fitzgerald analyst Alethia Young maintained a Buy rating on Celgene (CELG – Research Report) today and set a price target of $100. The company’s shares closed yesterday at $66.64, close to its 52-week low of $58.59. Young said: “We